[Granulocyte-colony stimulating factor-producing multiple myeloma presenting with neutrophilia]

Momoko Yokoi1, Toshinori Kondo1, Risa Shimizu1

  • 1Department of Hematology, Kawasaki Medical School.

Insights

G-CSF-producing myeloma is a rare condition where myeloma cells secrete granulocyte-colony stimulating factor (G-CSF), leading to neutrophilia. This case highlights successful treatment with daratumumab, lenalidomide, and dexamethasone, normalizing G-CSF levels and neutrophil counts.

Area of Science:

  • Hematology
  • Oncology

Background:

  • Multiple myeloma is a plasma cell malignancy characterized by M proteinemia.
  • Granulocyte-colony stimulating factor (G-CSF) is crucial for neutrophil production.
  • G-CSF-producing myeloma is a rare subtype associated with neutrophilia.

Observation:

  • A 71-year-old woman presented with nausea and anorexia, exhibiting neutrophilia and M proteinemia.
  • Elevated serum G-CSF levels (160 pg/ml) and bone marrow plasmacytosis were noted.
  • Immunohistochemistry confirmed G-CSF production by myeloma cells.

Findings:

  • The patient was diagnosed with G-CSF-producing myeloma, with a negative CSF3R-T618I mutation.
  • Treatment with daratumumab, lenalidomide, and dexamethasone achieved a very good partial response.
  • Serum G-CSF levels and neutrophil counts normalized post-treatment.

Implications:

  • G-CSF-producing myeloma requires specific diagnostic approaches, including serum G-CSF measurement and IHC.
  • This case demonstrates the efficacy of novel therapies in managing this rare myeloma subtype.
  • Further research is needed to understand the clinical characteristics and long-term prognosis of G-CSF-producing myeloma.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
982
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K